ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03033511
Brief Title: A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) (MERU)

First Submitted : January 25, 2017
First Submitted that Met QC Criteria : January 25, 2017
First Posted : January 26, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : November 2, 2018
Last Update Posted : November 5, 2018